Peter Taylor

70PUBLICATIONS
127CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRheumatology and arthritisImmunogenetics (incl. genetic immunology)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Mar 04, 2026
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study.

Peter C Taylor, Georg Schett, Tom W J Huizinga

|Jan 30, 2026
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial.

Josef S Smolen, Ted R Mikuls, James Galloway

|Jan 08, 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies.

Peter C Taylor, Arthur Kavanaugh, Louis Bessette

|Dec 30, 2025
Cross-speciality collaborative care in complex immune-mediated inflammatory diseases: treating the person living with the condition.

Peter C Taylor, Laura Savage, Christine Bundy

|Jul 11, 2025
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.

Peter C Taylor, Thomas Bieber, Rieke Alten

|Jun 03, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease.

Pageof 12

Frequent Collaborators

9 joint publications

Yoshiya Tanaka

7 joint publications

Tsutomu Takeuchi

4 joint publications

Line Uhrenholt

4 joint publications

Robin Christensen